Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
Korean cancer screening company seeks investment.
| Project region | South Korea |
|---|---|
| Industry | Biomedicine |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Vivian Mao
Partner
| Project highlights | nanoscale controllable - 15 years' R&D and 20 million investment - patents registered in 12 countries |
|---|---|
| Project description |
The Korean company's core technology is nanoscale controllable surface coating technology. The company aims to reliably diagnose early human cancer through the highest sensitivity, specificity and lowest detection limit. Through 15 years of research and investment of USD 20 million, the company has completed the R&D of core technology. In vitro diagnosis ("IVD") has been applied and four cardiac lateral flow immunoassay ("LFA") (sidestream analysis) kits have been completed pilotscale experiment. The company has registered patents in 12 countries including the United States and the European Union. The company now seeks investment. |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us